I.V. infusion of hydroxyethyl starch 130/0.4 (6%) may be accompanied by a marked overestimation of fibrinogen concentration measured according to the Clauss method.
5
It also appears to impair clot formation. 6 This impairment is accompanied by an increase in transfusion requirements resulting in a decline in MCF. 6 This effect lasts approximately for up to 2 h, 7 can be reversed with i.v. fibrinogen, and seems to be due to interference with formation of fibrin mesh.
6
Overestimation of fibrinogen concentration and interference with formation of fibrin mesh would explain the initial finding of a lower fibTEM MCF than expected, with a fibrinogenaemia of 3.19 g litre 21 . 4 Meanwhile, both the treatment and disappearance of the effects of hydroxyethyl starch would explain the progressive increase in fibTEM MCF in spite of stable fibrinogen levels. In conclusion, hydroxyethyl starch 130/0.4 (6%) seems to be a friend to haemodynamics and a foe for haemostasis. Treatment of a life-threatening laryngeal bradykinin angio-oedema precipitated by dipeptidylpeptidase-4 inhibitor and angiotensin-I converting enzyme inhibitor with prothrombin complex concentrates
Editor-Some drugs such as angiotensin-I converting enzyme inhibitors (ACEi) and dipeptidylpeptidase-4 (DPP-4) inhibitors can precipitate bradykinin angio-oedema (AE) attributable to the inhibition of the enzymes involved in bradykinin catabolism and affecting kinin B1 and B2 receptor signalling.
1
A 67-yr-old man presented at the emergency department with laryngeal oedema and severe dyspnoea which had developed over 3 h. He had a history of type 2 diabetes treated with metformin and DPP-4 inhibitor (sitagliptin) introduced 2 months before, hypertension for which he took ACEi (perindopril) for 10 yr, and a pulmonary embolism requiring anti-vitamin K (AVK) medication. This was the third episode within a month; the first two episodes of AE had regressed in ,48 h after treatment with anti-histamines and corticosteroids. In this episode, significant glosso-pharyngo-laryngeal oedema ( Fig. 1 ) was responsible for coughing, dysphonia, and difficulty in swallowing, dyspnoea, and oxygen saturation of 92% on masked-delivered O 2 at 5 litre min
21
. The patient was immediately treated with epinephrine aerosols, i.v. dexchlorpheniramine 5 mg, and methylprednisolone 120 mg. The patient showed no improvement in the next hour. In anticipation of a difficult intubation or a life-saving tracheotomy, AVK antagonist, Kanokad w (LFB, France) 1500 IU, was administered. Dyspnoea and dysphonia regressed within 20 min, and symptoms completely disappeared within 8 h (Fig. 2) ) and function were normal. The search for auto-antibodies was negative. After 36 h of observation in intensive care unit, the patient was discharged completely free of symptom. In the following weeks, he returned twice with a similar presentation, which completely resolved within 1 h of 1000 UI C1-inh concentrate (Berinert w , CSL Behring) on the fourth episode, and within half-an-hour after injection of icatibant (Firazyr w , Shire) on the fifth episode. This patient presented with laryngeal distress. Allergic causation was excluded on the basis of lack of effects of steroids and anti-histamines. The diagnosis considered was drug-induced bradykinin AE. The absence of similar family history, the late onset of the first symptoms, and the normality of the complement pathway excluded C1-inh deficiency. He had been taking ACEi for more than 10 yr and DPP-4 inhibitors for 2 months, with these symptoms occurring for 1 month. ACE is an important kininase, playing a major role in bradykinin degradation and inactivation. with subsequent 50 mg C1-inh administered to the patient. C1-inh efficiently controls the activation of kinin forming enzymes with conversion of kininogen into bradykinin. Drug-induced bradykinin AE should be considered for facial or laryngeal oedema resistant to anti-histaminic and corticosteroids, with no evident allergic causation if the patient takes ACEi or DPP-4 inhibitor. In cases of respiratory distress, standard PCC Kanokad w may be a life-saving treatment. Simplified estimation of ideal and lean body weights in morbidly obese patients The equation is y ¼ a x, where y is IBW or LBW, x the h 2 , and a the best-fit, gender-specific BMI (kg m 22 ) for use in the simplified equation:
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IBW or LBW ¼ BMI (best-fit) h 2 . Data were obtained from 200 consecutive MO male patients and 200 consecutive MO female patients who underwent bariatric surgery in our University Hospital. Statistical analyses were performed with SAS for Windows, version 9.2 (SAS Institute Inc., Cary, NC, USA). 95% CI, 95% confidence intervals for the regression parameters.
